Syngene Appoints VWR International as New Canadian Distributor
News Mar 28, 2013
Syngene, a world-leading manufacturer of image analysis solutions is delighted to announce that it is strengthening its Canadian presence with the appointment of respected distributors, VWR International, allowing life scientists in Canada to easily access Syngene’s unrivalled image analysis technology.
Syngene has appointed VWR International to market its equipment in Canada because the firm is an established manufacturer’s representative with specialist knowledge of image analysis. VWR has a network of 60 scientific sales professionals and 6 life science specialists who will provide sales and technical support for Syngene’s high quality gel documentation and image analyzer range, which includes Syngene’s latest PXi systems for imaging and analyzing DNA and protein gels.
Michael Ratos, Vice President of Marketing Canada, VWR International commented: “We always look to offer best in class products for our customers and the Syngene image analysis systems are exactly that. The image analyzers offer the best value for money and perfectly complement the other products we provide for DNA and protein analysis so we’re delighted to add them to our product portfolio.”
Ratos added: “We are especially impressed with the PXi range of image analyzers because they are cost-competitive. The GeneSys software which comes with the PXi is user friendly, which means it is quick and easy to set up and demonstrate to life scientists. The support we have had from Syngene’s technical team has been fabulous and their training has helped us really understand the products. We’re looking forward to a long association with Syngene.”
Laura Sullivan, Syngene’s Divisional Manager concluded: "We have had great success recently in the North American market with our image analyzers and are supporting this growth by adding VWR’s extensive network of technical specialists to our team. VWR is a first-class distributor and we know that through their professional approach, Syngene’s excellent reputation for delivering performance and service will be extended to all our existing and potential Canadian life science clients.”
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
New Algorithms Help Extract 3-D Biological Structure from Limited DataNews
CAMERA researchers capitalize on their Multi-Tiered Iterative Phasing approach to determine molecular structure of proteins and viruses from X-ray free electron laser data.READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Introduction to Next Generation Sequencing
Apr 09 - Apr 12, 2018
EMBL Course: Introduction to Metabolomics Analysis
Mar 20 - Mar 23, 2018
EMBL Course: RNA Sequencing Library Preparation - How Low Can You Go?
Mar 19 - Mar 23, 2018